The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer

por Hemdan, T, Lindén, M, B Lind, S, V Namuduri, A, Sjöstedt, E, D de Ståhl, T, Asplund, A, Malmström, P-U, Segersten, U
Publicado 2014

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer

por Boman, K, Larsson, A H, Segersten, U, Kuteeva, E, Johannesson, H, Nodin, B, Eberhard, J, Uhlén, M, Malmström, P-U, Jirström, K
Publicado 2013

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR

por Dyrskjøt, L, Reinert, T, Novoradovsky, A, Zuiverloon, T C M, Beukers, W, Zwarthoff, E, Malats, N, Real, F X, Segersten, U, Malmström, P-U, Knowles, M, Hurst, C, Sorge, J, Borre, M, Ørntoft, T F
Publicado 2012